Sarepta Therapeutics, Inc. (SRPT)
17.19
+0.53
(+3.18%)
USD |
NASDAQ |
Mar 17, 13:09
Sarepta Therapeutics Total Liabilities (Quarterly) : 2.209B for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co., Inc. | 84.20B |
| REGENXBIO, Inc. | 350.30M |
| Keros Therapeutics, Inc. | 39.74M |
| Gilead Sciences, Inc. | 36.40B |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.350B |
| Shareholders Equity (Quarterly) | 1.141B |
| Debt to Equity Ratio | 0.9114 |
| Current Ratio | 2.317 |
| Net Debt Paydown Yield | 3.17% |